Healthcare provider profile · identity verified

Jitendra P Katneni, MD

Internal Medicine · FLINT, MI · NPI 1710949813

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	994	275
Amlodipine Besylate	Amlodipine Besylate	687	201
Levothyroxine Sodium	Levothyroxine Sodium	597	158
Losartan Potassium	Losartan Potassium	577	171
Metoprolol Succinate	Metoprolol Succinate	570	171
Rosuvastatin Calcium	Rosuvastatin Calcium	441	145
Allopurinol	Allopurinol	391	112
Metoprolol Tartrate	Metoprolol Tartrate	306	91
Famotidine	Famotidine	288	110
Metformin Hcl	Metformin Hcl	251	74
Potassium Chloride	Potassium Chloride	249	72
Omeprazole	Omeprazole	242	65
Eliquis	Apixaban	223	58
Ezetimibe	Ezetimibe	221	67
Torsemide	Torsemide	221	71
Ozempic	Semaglutide	206	36
Carvedilol	Carvedilol	191	53
Tamsulosin Hcl	Tamsulosin Hcl	178	54
Trazodone Hcl	Trazodone Hcl	169	51
Hydrochlorothiazide	Hydrochlorothiazide	165	56
Clopidogrel	Clopidogrel Bisulfate	164	45
Simvastatin	Simvastatin	159	43
Lisinopril	Lisinopril	146	48
Pantoprazole Sodium	Pantoprazole Sodium	137	49
Buspirone Hcl	Buspirone Hcl	134	50
Calcitriol	Calcitriol	133	38
Telmisartan	Telmisartan	129	37
Gabapentin	Gabapentin	128	55
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	126	37
Escitalopram Oxalate	Escitalopram Oxalate	118	29
Furosemide	Furosemide	116	34
Glimepiride	Glimepiride	112	33
Jardiance	Empagliflozin	111	34
Mirtazapine	Mirtazapine	100	31
Duloxetine Hcl	Duloxetine Hcl	96	26
Montelukast Sodium	Montelukast Sodium	94	27
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	92	29
Meloxicam	Meloxicam	90	47
Isosorbide Mononitrate Er	Isosorbide Mononitrate	89	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	83	27
Verapamil Er	Verapamil Hcl	81	21
Pravastatin Sodium	Pravastatin Sodium	80	21
Azithromycin	Azithromycin	78	67
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	78	42
Bisoprolol Fumarate	Bisoprolol Fumarate	77	25
Finasteride	Finasteride	74	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	71	26
Spironolactone	Spironolactone	71	24
Nifedipine Er	Nifedipine	69	19
Bupropion Xl	Bupropion Hcl	68	18
Ramipril	Ramipril	67	20
Sertraline Hcl	Sertraline Hcl	66	24
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	65	22
Fenofibrate	Fenofibrate Nanocrystallized	64	17
Albuterol Sulfate Hfa	Albuterol Sulfate	60	31
Januvia	Sitagliptin Phosphate	58	22
Quetiapine Fumarate	Quetiapine Fumarate	57	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	56	16
Prednisone	Prednisone	55	37
Metformin Hcl Er	Metformin Hcl	53	22
Memantine Hcl	Memantine Hcl	50	18
Mounjaro	Tirzepatide	50	15
Raloxifene Hcl	Raloxifene Hcl	50	14
Doxazosin Mesylate	Doxazosin Mesylate	49	15
Hydralazine Hcl	Hydralazine Hcl	48	21
Venlafaxine Hcl Er	Venlafaxine Hcl	46	15
Entresto	Sacubitril/Valsartan	43	suppressed
Metolazone	Metolazone	42	13
Tradjenta	Linagliptin	42	11
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	42	20
Fluticasone Propionate	Fluticasone Propionate	41	21
Donepezil Hcl	Donepezil Hcl	40	13
Xarelto	Rivaroxaban	40	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	39	suppressed
Citalopram Hbr	Citalopram Hydrobromide	37	suppressed
Irbesartan	Irbesartan	37	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	13
Dicyclomine Hcl	Dicyclomine Hcl	36	16
Doxycycline Hyclate	Doxycycline Hyclate	34	26
Bumetanide	Bumetanide	33	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	33	suppressed
Atenolol	Atenolol	32	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	32	20
Diclofenac Sodium	Diclofenac Sodium	31	17
Humalog Kwikpen U-100	Insulin Lispro	31	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	31	27
Benazepril Hcl	Benazepril Hcl	30	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	29	suppressed
Farxiga	Dapagliflozin Propanediol	29	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	28	suppressed
Clonidine Hcl	Clonidine Hcl	28	suppressed
Rivastigmine	Rivastigmine Tartrate	28	11
Janumet	Sitagliptin Phos/Metformin Hcl	27	suppressed
Novolog Flexpen	Insulin Aspart	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	24
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	26	12
Fenofibrate	Fenofibrate	26	suppressed
Risedronate Sodium	Risedronate Sodium	25	suppressed
Diltiazem Hcl	Diltiazem Hcl	24	suppressed
Glipizide Er	Glipizide	23	suppressed
Indapamide	Indapamide	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Verapamil Sr	Verapamil Hcl	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	22	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	22	suppressed
Ipratropium Bromide	Ipratropium Bromide	22	13
Pregabalin	Pregabalin	22	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Febuxostat	Febuxostat	19	suppressed
Niacin Er	Niacin	19	suppressed
Hydrocortisone	Hydrocortisone	18	14
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	17	suppressed
Cholestyramine	Cholestyramine (With Sugar)	17	suppressed
Glipizide	Glipizide	17	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	17	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Acyclovir	Acyclovir	15	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	11
Colchicine	Colchicine	15	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	11
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	15	suppressed
Brilinta	Ticagrelor	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Isosorbide Dinit-Hydralazine	Isosorbide Dinit/Hydralazine	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	11
Chlorthalidone	Chlorthalidone	13	suppressed
Cilostazol	Cilostazol	13	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Ketoconazole	Ketoconazole	13	11
Lactulose	Lactulose	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Diclofenac Sodium-Misoprostol	Diclofenac Sodium/Misoprostol	12	suppressed
Digoxin	Digoxin	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Nadolol	Nadolol	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Repaglinide	Repaglinide	12	suppressed
Tiotropium Bromide	Tiotropium Bromide	12	suppressed
Topiramate	Topiramate	12	suppressed
Atrovent Hfa	Ipratropium Bromide	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Levofloxacin	Levofloxacin	11	11
Linzess	Linaclotide	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error